Aware Recovery Care and the In-Home Addiction Treatment Institute announce a collaboration with Dr. Frank Buono, Ph.D. (Department of Psychiatry at Yale School of Medicine) to conduct a pilot randomized controlled trial to evaluate the usage and initial acceptability of the Soberlink device. The project is planned to get underway in June 2020 with an expected completion date of 2022.
Soberlink is a comprehensive alcohol monitoring system designed to remotely monitor a person’s Blood Alcohol Concentration (BAC). Combining a professional-grade handheld breathalyzer with wireless connectivity, the technology includes real-time facial recognition, robust tamper detection, and real-time alerting.
This single-arm experiment will recruit individuals working with Aware Recovery Care who are suffering from alcohol use disorder.
The study will attempt to test the following aims:
- To determine the effectiveness of Soberlink’s ability to increase abstinence.
- To evaluate the impact of Soberlink’s device on the participant based on their quality of health and sobriety.
- To evaluate the extent to which the need for higher levels of follow-up care and treatment is reduced for individuals who have had access to the Soberlink device.
For more information about this study, please contact Tracie Samuelson at tsamuelson@awarerecoverycare.com.
